# Integrating the Genetic and Metabolic Faces of Obesity

> **NCT00285844** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 88 (actual)

## Conditions studied

- Insulin Resistance
- Obesity
- Metabolic Syndrome

## Interventions

- **BEHAVIORAL:** weight loss
- **DRUG:** thiazolidinedione

## Key facts

- **NCT ID:** NCT00285844
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00285844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00285844, "Integrating the Genetic and Metabolic Faces of Obesity". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00285844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*